modified FOLFIRINOX (mFOLFIRINOX)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for modified FOLFIRINOX (mFOLFIRINOX), covering 2025-09-23 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer [Phase 3]